Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

The first day of flu and COVID shots set a single-day record, with 82,000 shots administered through B.C. pharmacies ...

WA Premier Roger Cook has called on Port Hedland councillor Adrian McRae to quit after quoting a Nazi and attacking Western ...

Nearly 10.4M New Yorkers, or 53%, got the flu shot last year. Only about 12% got the COVID shot. Here's why, how officials ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The UK Government has recommended offering a COVID-19 booster vaccination in autumn, 2024, to individuals at high risk of ...

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

Record numbers of people in British Columbia are being vaccinated against COVID-19 and flu, as the province ramps up its ...

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...